Overview of Myelodysplastic Syndrome

Targeted Therapy for MDS (April 20, 2006)

Overview A targeted therapy is one that is designed to treat the cancer cells and minimize damage to normal, healthy cells. Cancer treatments that “target” cancer cells may offer the advantage of reduced... Continue Reading

Strategies to Improve Treatment of MDS (April 20, 2006)

Overview The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Clinical trials are studies that evaluate the effectiveness of... Continue Reading

High-Dose Therapy with Stem Cell Transplant for MDS (April 19, 2006)

Overview High-doses of chemotherapy are more effective at killing cancer cells than lower doses. However, high-dose therapy destroys many other cells in the body. A dangerous side effect of administering... Continue Reading

Supportive Care of MDS: Blood Cell Growth Factors (April 19, 2006)

Overview While patients may not initially experience symptoms of their condition, the ineffective blood cell production that characterizes MDS eventually results in uncomfortable and life-threatening side... Continue Reading

Chemotherapy without SCT for MDS (April 19, 2006)

Overview Patients with MDS who are unable or unwilling to undergo a stem cell transplant using donor cells or those planning to have their own stem cells collected for a future transplant can receive conventional... Continue Reading

Overview of Myelodysplastic Syndrome (March 22, 2004)

Overview Myelodysplastic syndromes (MDS) are a group of diseases marked by abnormal production of blood cells by the bone marrow. Healthy bone marrow produces immature blood cells—called blasts—that... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS